Rising Medical Solutions Publishes 13th Annual Workers' Compensation Benchmarking Study Report

Rising Medical Solutions released its 2025 Workers' Compensation Benchmarking Study, finding that claims organizations with closure ratios of at least 101% outperform peers primarily through execution rather than differing strategic priorities. Higher performers manage more complex claims inventories while closing claims faster, supported by four practices: better initiative selection, reduced workflow friction, stronger employee adoption, and workforce capability building. The research is industry-focused and offers operational guidance, but contains no material financial results or company-specific outlook changes.

Analysis

This is not an earnings catalyst; it is directional evidence that workers' compensation loss-ratio dispersion is increasingly an operating-model issue rather than simply a pricing or claim-mix issue. For TRV, HIG and THG, durable advantage comes from shortening claim duration while controlling medical severity: faster closure releases loss reserves sooner, reduces indemnity leakage and can improve accident-year development. The financial impact is likely gradual and only investable when corroborated by calendar-year reserve development, workers' compensation combined-ratio commentary, and expense-ratio trends.

TRV is the most relevant public read-through given its scale and explicit participation in the underlying industry dialogue. Better claims execution can support modest reserve releases and underwriting-margin resilience over 6-18 months, but the market is unlikely to award a higher multiple based on survey evidence alone; pricing normalization, wage inflation and medical-cost trend remain much larger drivers. HIG and THG may benefit similarly, although their smaller workers' compensation exposure makes any earnings effect less visible at the consolidated level.

The second-order beneficiary is ACI: improved employer-side injury management and return-to-work processes can lower self-insured workers' compensation expense and absenteeism, though this is immaterial to near-term valuation. Contrarian view: insurers broadly describe claims technology and workflow initiatives as margin opportunities, but implementation costs, vendor spend and frontline adoption can initially raise expense ratios before severity benefits emerge. Watch Q3/Q4 carrier disclosures for claim-count closure rates, average claim duration, medical severity and favorable/adverse prior-year development; absent measurable improvement, this remains non-actionable industry research rather than a stock-specific catalyst.

Key Decisions for Investors

• No standalone trade on this release; treat it as a diligence flag ahead of 3Q/4Q results rather than a near-term catalyst.
• Maintain a relative-quality bias toward TRV versus HIG or THG over the next 6-12 months only if TRV reports stable/improving workers' compensation loss development and an expense ratio that does not deteriorate from claims-transformation investment.
• Set an earnings-watch trigger for TRV: add on evidence of favorable prior-year workers' compensation development plus declining claim duration/medical severity; negate the thesis if reserve development turns adverse or the underlying combined ratio worsens by more than 200 bps without pricing offset.
• For ACI, monitor workers' compensation and self-insurance expense in annual disclosures as a minor confirmation of operational savings, not a basis for positioning; grocery wage inflation and competitive pricing dominate the equity thesis.